Literature DB >> 29784188

Late-onset tractional fibrovascular proliferation post-intravitreal bevacizumab following treatment of retinopathy of prematurity.

Swati Agarwal-Sinha1, Jade Gieseke Guevara2, Sarina M Amin2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29784188     DOI： 10.1016/j.jcjo.2017.09.028

Source DB:  PubMed          Journal:  Can J Ophthalmol        ISSN： 0008-4182            Impact factor:   1.882


× No keyword cloud information.
  2 in total

1.  Fluorescein Angiography in Retinopathy of Prematurity: Comparison of Infants Treated with Bevacizumab to Those with Spontaneous Regression.

Authors:  Sasha A Mansukhani; Amy K Hutchinson; Rebecca Neustein; Joseph Schertzer; John C Allen; G Baker Hubbard
Journal:  Ophthalmol Retina       Date:  2019-01-31

2.  Long-term retinal vasculature abnormalities following intravitreal bevacizumab for retinopathy of prematurity.

Authors:  Amir Sternfeld; Safa Rahmani; Jennifer L Rossen; David L Zhang; Yuping D Li; Victor L Quan; Russell Huang; Hawke H Yoon
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-12-01       Impact factor: 3.117
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.